Research
Hormonal
Glucagon stimulates lipolysis in rodent adipocytes but has no significant lipolytic effect on human adipocytes at physiological concentrations.
Unlike in mice, glucagon does not directly trigger significant fat breakdown in human fat cells at normal levels. Its main job in lipid metabolism is managing fat in the liver, not burning fat from storage cells.
GoodQualifiesHIGH confidence
Glucagon has been reported to activate HSL and lipolysis in rat adipocytes... At physiological plasma concentrations (1–40 pM), a lipolytic effect of glucagon in human adipocytes has been difficult to demonstrate.
Why this rating
The paper reviews multiple human studies showing lack of effect at physiological doses, contrasting with rodent data.
Source
Glucagon Receptor Signaling and Lipid Metabolism
Katrine D. Galsgaard et al. · Frontiers in Physiology · 2019
DOI 10.3389/fphys.2019.00413
narrative_reviewCited 204×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →